Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Highlights
American Society of Hematology (ASH)
ASH 2019 – Multiple Myeloma
Leslie Lauersdorf, ARNP
Moffitt Cancer Center
Tampa Bay, FL
Authored Items
What is Minimal Residual Disease (MRD) Negativity?
By
Leslie Lauersdorf, ARNP
American Society of Hematology (ASH)
ASH 2019 – Multiple Myeloma
Leslie Lauersdorf breaks down what it means to be MRD negative and how she explains MRD negativity to her patients.
Read More ›
Multiple Myeloma as a Chronic Disease
By
Leslie Lauersdorf, ARNP
American Society of Hematology (ASH)
ASH 2019 – Multiple Myeloma
As multiple myeloma moves toward being considered a chronic disease, nurses and navigators have new considerations to keep in mind when treating their patients.
Read More ›
Triplets versus Quads
By
Leslie Lauersdorf, ARNP
American Society of Hematology (ASH)
ASH 2019 – Multiple Myeloma
Leslie Lauersdorf explains triplet versus quad regimens in relation to multiple myeloma.
Read More ›
CAR T-Cell Data in Multiple Myeloma
By
Leslie Lauersdorf, ARNP
American Society of Hematology (ASH)
ASH 2019 – Multiple Myeloma
Leslie Lauersdorf discusses key considerations for nurses and navigators surrounding the use of CAR T-cell therapy in multiple myeloma.
Read More ›
Latest Developments in Multiple Myeloma
By
Leslie Lauersdorf, ARNP
American Society of Hematology (ASH)
ASH 2019 – Multiple Myeloma
Leslie Lauersdorf provides an overview of some of the most exciting clinical developments in multiple myeloma based on data presented at ASH 2019.
Read More ›
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us